Andreas Spittler

Dr. Andreas Spittler

Department of Surgery and Core Facility Flow Cytometry, Medical University of Vienna, Vienna, Austria
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2017 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
DMDolly Mushahary
Dolly Mushahary
Andreas SpittlerAndreas Spittler
Andreas Spittler
Cornelia KasperCornelia Kasper
Cornelia Kasper
VWViktoria Weber
Viktoria Weber
VCVerena Charwat
Verena Charwat

2 February 2006 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
KSKambis Sadeghi
Kambis Sadeghi
Barbara WessnerBarbara Wessner
Barbara Wessner
ULUte Laggner
Ute Laggner
MPMartin Ploder
Martin Ploder
DTDietmar Tamandl
Dietmar Tamandl
Andreas SpittlerAndreas Spittler
Andreas Spittler
Toll‐like receptors (TLR) represent an ancient front‐line defence system that enables the host organism to sense the presence of microbial components within minutes. As inducers of inflammation, TLR act as important triggers of distinct entities such as sepsis or autoimmune disease exacerbation. We report here that vitamin D3 [1α,25‐dihydroxycholecalciferol, 1,25(OH)2D3] suppresses the expression of TLR2 and TLR4 protein and mRNA in human monocytes in a time‐ and dose‐dependent fashion. Despite 1,25(OH)2D3‐induced up‐regulation of CD14, challenge of human monocytes with either LPS or lipoteichoic acid resulted in impaired TNF‐α and procoagulatory tissue factor (CD142) production, emphasizing the critical role of TLR in the induction of inflammation. Moreover, reduced TLR levels in 1,25(OH)2D3‐treated phagocytes were accompanied by impaired NF‐κB/RelA translocation to the nucleus and by reduced p38 and p42/44 (extracellular signal‐regulated kinase 1/2) phosphorylation upon TLR‐ligand engagement. Both TLR down‐regulation and CD14 up‐regulation were substantially inhibited by the vitamin D receptor (VDR) antagonist ZK 159222, indicating that the immunomodulatory effect of 1,25(OH)2D3 on innate immunity receptors requires VDR transcription factor activation. Our data provide strong evidence that 1,25(OH)2D3 primes monocytes to respond less effectively to bacterial cell wall components in a VDR‐dependent mechanism, most likely due to decreased levels of TLR2 and TLR4.

1 January 2017 in Cell
Verified
Journal Article
Open access
JLJin Li
Jin Li
TCTamara Casteels
Tamara Casteels
TFThomas Frogne
Thomas Frogne
CICamilla Ingvorsen
Camilla Ingvorsen
CHChristian Honoré
Christian Honoré
SKStefan Kubicek
Stefan Kubicek
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types, including glucagon-producing α cells. In a genetic model, loss of the master regulatory transcription factor Arx is sufficient to induce the conversion of α cells to functional β-like cells. Here, we identify artemisinins as small molecules that functionally repress Arx by causing its translocation to the cytoplasm. We show that the protein gephyrin is the mammalian target of these antimalarial drugs and that the mechanism of action of these molecules depends on the enhancement of GABAA receptor signaling. Our results in zebrafish, rodents, and primary human pancreatic islets identify gephyrin as a druggable target for the regeneration of pancreatic β cell mass from α cells.

1 December 2005 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
WDWolf-Dietrich DöcKe
Wolf-Dietrich DöcKe
CHConny HöfLich
Conny HöfLich
KDKenneth A Davis
Kenneth A Davis
KRKarsten RötTgers
Karsten RötTgers
CMChristian Meisel
Christian Meisel
DKDagmar Kunz
Dagmar Kunz
Background: Single-center trials have shown that monocytic HLA-DR is a good marker for monitoring the severity of temporary immunodepression after trauma, major surgery, or sepsis. A new test for measuring monocytic HLA-DR is now available. Methods: We evaluated a new test reagent set for monocytic HLA-DR expression (BD Quantibrite™ HLA-DR/Monocyte reagent; Becton Dickinson) in single-laboratory and interlaboratory experiments, assessing preanalytical handling, lyse-no-wash (LNW) vs lyse-wash (LW) values, reference values, and the effect of use of different flow cytometers and different instrument settings on test variance. Results: For preanalytical handling, EDTA anticoagulation, storage on ice as soon as possible, and staining within 4 h after blood collection gave results comparable to values obtained for samples analyzed immediately after collection (mean increase of ∼4% in monocytic HLA-DR). Comparison of LNW and LW revealed slightly higher results for LNW (∼18% higher for LNW compared with LW; r = 0.982). Comparison of different flow cytometers and instrument settings gave CVs <4%, demonstrating the independence of the test from these variables and suggesting that this method qualifies as a standardized test. CV values from the interlaboratory comparison ranged from 15% (blood sample unprocessed before transport) to 25% (stained and fixed before transport). Conclusions: For the BD Quantibrite HLA-DR/Monocyte test, preanalytical handling is standardized. Single-laboratory results demonstrated the independence of this test from flow cytometer and instrument settings. Interlaboratory results showed greater variance than single-laboratory values. This interlaboratory variance was partly attributable to the influence of transport and can be reduced by optimization of transport conditions.

21 December 2015 in EMBO Reports
Verified
Journal Article
Open access
PDF file
JLJin Li
Jin Li
JKJohanna Klughammer
Johanna Klughammer
MFMatthias Farlik
Matthias Farlik
TPThomas Penz
Thomas Penz
Andreas SpittlerAndreas Spittler
Andreas Spittler
SKStefan Kubicek
Stefan Kubicek
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 January 2007 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
KSKambis Sadeghi
Kambis Sadeghi
ABAngelika Berger
Angelika Berger
MLMichaela Langgartner
Michaela Langgartner
APAndrea‐Romana Prusa
Andrea‐Romana Prusa
MHMichael Hayde
Michael Hayde
EFElisabeth Förster-Waldl
Elisabeth Förster-Waldl
The impaired infection control related to the functional immaturity of the neonatal immune system is an important cause of infection in preterm newbo